Zhang, Haixian, Song, Feifei, Dong, Caihong, Yu, Luodan, Chang, Cai, and Chen, Yu
Additional file 1: Methods. 1.1 In vitro DSF release of DSF@HMONs; 1.2 In vitro photothermal effect of CuS; 1.3 In vitro cytotoxicity assay of HMONs. Figure S1. The releasing profiles of DSF from DSF@HMONs in aqueous solutions. Figure S2. In vitro photothermal-conversion assessment of CuS. Figure S3. Relative cell viability of 4T1 cancer cells after incubation with different concentrations (0, 6.25, 12.5, 25, 50, 100, and 200 ��g/mL) of HMONs for 24 and 48 h. Figure S4. Blood routine examination and serum biochemical levels of mice treated with 0 mg/kg, 5 mg/kg, 10 mg/kg, and 20 mg/kg of DSF@HCu. Figure S5. Histopathological examinations of major organs (heart, liver, spleen, lung, and kidney) from mice after different treatments.